Walleye Capital’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,300
Closed -$73K 1485
2019
Q4
$73K Sell
13,300
-110,700
-89% -$623K ﹤0.01% 1432
2019
Q3
$709K Buy
124,000
+121,300
+4,493% +$824K 0.04% 584
2019
Q2
$21K Sell
2,700
-3,300
-55% -$17.8K ﹤0.01% 1524
2019
Q1
$32K Buy
+6,000
New +$41.6K 0.01% 1290

Other funds holding PGEN

Walleye Capital's PGEN Position: Q3 2021 in Review

Walleye Capital sold out of Precigen (PGEN) in Q3 2021, closing a stake of 10,496 shares — an estimated $68 sold.

Walleye Capital first reported a position in PGEN in Q1 2019 and held it in 4 quarters. The position peaked at $194K in Q3 2019. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

  • Walleye Capital reported no remaining Precigen position as of Q3 2021 after selling out during the quarter.
  • Walleye Capital sold 10,496 Precigen shares in Q3 2021, an estimated $68.
  • Walleye Capital first reported a position in Precigen in Q1 2019 and held it in 4 quarters.
  • Walleye Capital's Precigen position peaked at $194K in Q3 2019.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on Walleye Capital's 13F filing for Q3 2021, filed 15 Nov 2021.